drugset / Trial / NCT05474027

Reducing Hypotensive Anesthesia Use With TXA During Orthognathic Surgery

NCT05474027 ↗

Phase 4 Completed 115 enrolled University of Alabama at Birmingham
NaSingle-groupOpen-labelOther

Summary

This prospective study will analyze the need for deliberate hypotensive anesthesia (DHA) during orthognathic surgery when tranexamic acid (TXA) is administered. DHA has been proven to be effective although it comes with multiple risks related to organ hypoperfusion including kidney injury, stroke, and cardiac ischemia. Therefore, it may be potentially safer for patients to avoid deliberate hypotensive anesthesia if TXA alone adequately controls blood loss and provides adequate surgical site visualization.

Timeline

Start
2022-11-11
Primary completion
2025-11-11
Completion
2025-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1 g Intravenous